Pharmaceutical Firm ArTec, Inc., Announces Testing Launch of TUBERCIN(TM) -- Mission Focus is on the Testing of HIV/AIDS & Tuberculosis Patients in South Africa

OKLAHOMA CITY--(BUSINESS WIRE)--ARTEC, Inc., (Pink Sheets: ATKJ), visionary pharmaceutical firm, has acquired the preliminary outline to be used for the testing protocol from a sponsoring scientific group in South Africa for TUBERCINTM, a revolutionary polysaccharide compound to be used as an HIV/AIDS and ANTI-CANCER immunostimulant.
MORE ON THIS TOPIC